![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Springe zu: 2025
Anzahl der Publikationen: 1
2025
Berclaz, Luc M. 
ORCID: https://orcid.org/0000-0003-4405-138X; Jurinovic, Vindi; Burkhard‐Meier, Anton; Abdel‐Rahman, Sultan; Albertsmeier, Markus ORCID: https://orcid.org/0000-0002-5028-5062; Klein, Alexander; Dürr, Hans Roland ORCID: https://orcid.org/0000-0002-1347-1173; Schmidt‐Hegemann, Nina‐Sophie; Knösel, Thomas ORCID: https://orcid.org/0000-0002-1822-0197; Kunz, Wolfgang G. ORCID: https://orcid.org/0000-0002-5021-1952; Stutz, Emanuel; Bergwelt‐Baildon, Michael von; Gioia, Dorit Di und Lindner, Lars H. ORCID: https://orcid.org/0000-0003-3708-8264
(2025):
Doxorubicin Plus Dacarbazine Versus Doxorubicin Plus Ifosfamide in Combination With Regional Hyperthermia in Patients With Advanced Leiomyosarcoma: A Propensity Score‐Matched Analysis.
In: Cancer Medicine, Bd. 14, Nr. 4, e70655
[PDF, 750kB]
ORCID: https://orcid.org/0000-0003-4405-138X; Jurinovic, Vindi; Burkhard‐Meier, Anton; Abdel‐Rahman, Sultan; Albertsmeier, Markus ORCID: https://orcid.org/0000-0002-5028-5062; Klein, Alexander; Dürr, Hans Roland ORCID: https://orcid.org/0000-0002-1347-1173; Schmidt‐Hegemann, Nina‐Sophie; Knösel, Thomas ORCID: https://orcid.org/0000-0002-1822-0197; Kunz, Wolfgang G. ORCID: https://orcid.org/0000-0002-5021-1952; Stutz, Emanuel; Bergwelt‐Baildon, Michael von; Gioia, Dorit Di und Lindner, Lars H. ORCID: https://orcid.org/0000-0003-3708-8264
(2025):
Doxorubicin Plus Dacarbazine Versus Doxorubicin Plus Ifosfamide in Combination With Regional Hyperthermia in Patients With Advanced Leiomyosarcoma: A Propensity Score‐Matched Analysis.
In: Cancer Medicine, Bd. 14, Nr. 4, e70655
[PDF, 750kB]